Skip to main content
TipRanks
Go Ultimate75% OFF
Violet Therapeutics logo

Violet Therapeutics: Valuation, Funding & Investors

399 Revolution Dr Suite 999 Somerville, Massachusetts 02145, UShttps://www.violettx.com/Therapeutics

Violet Therapeutics is a preclinical-stage biotechnology company developing first-in-class therapies for neurodegenerative disease by mapping disease-relevant cell-to-cell signaling interactions in the brain. The company’s proprietary CONNECT platform is designed to identify therapeutically actionable signaling pathways that drive neuroinflammation, neurodegeneration, and synaptic loss.

Leadership & Board

Current Number of Employees
13
Current LinkedIn Followers
991

Latest Estimated Valuation

Total Amount Raised
$5M
Total Funding Rounds
1
Latest Funding Amount
$5M
Latest Funding Round
Seed Round

Employee Trend

Violet Therapeutics had 13 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

13Latest Employee Count
0(0.00%)Week-Over-Week Change
05101520Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

Violet Therapeutics had 991 followers as of November 16, 2026. The number of followers increased by 4 (0.41%) week-over-week.

991Latest Followers Count
4(0.41%)Week-Over-Week Change
05001,0001,5002,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
May 18, 2026Seed Round$4.75M―

Investors

Investor NameFunding Round
LifeSpan Vision VenturesSeed Round
Dementia Discovery FundSeed Round
UTECSeed Round
Ono Venture InvestmentSeed Round
Mass General Brigham VenturesSeed Round

Similar Companies

A snapshot of private companies similar to Violet Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis